FDBusiness.com

Epax Receive the Frost & Sullivan Award For Product Differentiation Excellence

 Breaking News
  • Lactalis Expands in Infant Nutrition With €740 Million Acquisition Lactalis Group, the international dairy group based in Laval, France, is acquiring the Nutritional business of Aspen Pharmacare for €739.8 million (R12.9 billion). The business being acquired supplies a wide range of infant nutritional and growing-up milk products across both the premium and value segments. It manufactures and markets well established quality brands, including S-26, [...]...
  • Thatchers Cider to Invest £14 Million in New Cider Mill Thatchers Cider, the family owned English cider producer, is to invest £14 million in a new cider mill at its Myrtle Farm site in Somerset to meet growing demand for its products. The company has applied for planning permission and, if granted, the new mill would come on stream in 2019. “This investment is about our [...]...
  • Coca-Cola Great Britain Teams Up With Premier League Premier League and Coca-Cola Great Britain have announced a new three-and-a-half-year partnership, starting in January 2019. It is the first sponsorship Coca-Cola Great Britain will activate across multiple brands within its portfolio, showcasing a range of drinks including sparkling soft drinks, water and fruit-based drinks, with low and no-sugar options. The partnership will see Coca-Cola work [...]...
  • Barry Callebaut Completes $30 Million Capacity Expansion in North America Barry Callebaut, the world’s leading manufacturer of high-quality chocolate and cocoa products, has announced the completion of several expansion investments in three of its North American facilities located in St Hyacinthe, Quebec; Chatham, Ontario; and St Albans, Vermont. The investments amount to close to US$30 million and are in line with previously announced plans. Recent investments [...]...
  • Strong First Half From Hilton Food Group Hilton Food Group, the UK-based leading specialist international food packing business, has reported a 25.0% increase in turnover to £863.6 million and by 24.5% on a constant currency basis for the 28 weeks to 15 July 2018. Volumes increased by 12.7% reflecting growth in the UK, Ireland and Australia. Operating profit for the first half [...]...

Epax Receive the Frost & Sullivan Award For Product Differentiation Excellence

Epax Receive the Frost & Sullivan Award For Product Differentiation Excellence
September 26
09:51 2012

Epax has received the Frost & Sullivan Product Differentiation Excellence Award. The award recognizes Epax’s condition-specific range of concentrated EPA/DHA omega-3 ingredient products and the company’s success in carving out a niche in a crowded market.

“Product differentiation is one of the prime factors that define success in the omega-3 market,” says Frost & Sullivan Research Analyst, Ashwin Raj Ravinder. “Epax abides by the strictest norms, right from choosing the raw material to final delivery, and they consistently deliver products with the best purity profile in the industry.”

The Epax product range contains an optimum EPA and DHA ratio that offers a cost-effective solution. Multiple clinical studies and the European Food Safety Authority (EFSA) approved health claims strengthen Epax’s marketability and presence.

“Consumers prefer health food and beverages that correspond to their specific ailments. Epax offers a comprehensive product range in the Omega-3 space that tackles condition-specific health concerns unlike other participants in the omega-3 category,” he adds.

Epax also received Frost & Sullivan’s Excellence in Product Quality Award in 2008, which demonstrates that Epax’ purity beyond expectation concept has consistently created value for customers for years. Epax’ customers have valuable brand equity at stake and depend on the highest quality ingredients. Epax delivers on this expectation by living Purity, Quality, Innovation™ every day.

“Epax is honored to be recognized by Frost & Sullivan for our commitment to ultra-pure and high quality condition-specific omega-3 ingredients,” says Ola Snøve, CEO of Epax. “Epax has invested significantly in new and innovative technologies and processes during the last two years and it is truly inspiring to receive this award as we are preparing together with our customers for the launch of our next generation products over the coming year.”

Epax is a 50/50 joint venture between Aker BioMarine and Lindsay Goldberg. Epax is the world leader in marine-derived omega-3 fatty acid concentrates. The company offers a wide range of high quality omega-3 concentrates in the nutraceutical business-to-business segment, as well as pharmaceutical intermediates and active pharmaceutical ingredients (API). The Epax group is headquartered in Oslo, Norway, with cGMP manufacturing facilities in Alesund, Norway and Seal Sands, UK.

About Author

mike

mike

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • September 25, 2018PPMA Show 2018
  • September 27, 2018Int'l Fruit Show (eurofruit)
  • September 30, 2018Trade Fair for Butchers, Caterers and Meat Industry (Meat Expo)
  • October 1, 2018Poznan International Fair
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements